SHREE GANESH REMEDIES Financial Statement Analysis
|
||
The Revenues of SHREE GANESH REMEDIES have increased by 96.65% YoY .
The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has increased by 87.57 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
SHREE GANESH REMEDIES Last 5 Annual Financial Results
[BOM: 540737]
Consolidated | Mar2024 | Mar2020 | Mar2019 |
---|---|---|---|
Revenues | ₹126 Cr | ₹64 Cr | ₹35 Cr |
Expenses | ₹84 Cr | ₹52 Cr | ₹27 Cr |
Operating Profit (Excl OI) | ₹42 Cr | ₹13 Cr | ₹8.74 Cr |
Other Income | ₹3.07 Cr | ₹3.91 Cr | ₹1.17 Cr |
Interest | ₹0.61 Cr | ₹0.54 Cr | ₹0.20 Cr |
Depreciation | ₹6.11 Cr | ₹2.30 Cr | ₹1.04 Cr |
Profit Before Tax | ₹38 Cr | ₹14 Cr | ₹8.67 Cr |
Profit After Tax | ₹28 Cr | ₹10 Cr | ₹6.24 Cr |
Consolidated Net Profit | ₹28 Cr | ₹10 Cr | ₹6.24 Cr |
Earnings Per Share (Rs) | ₹21.89 | ₹11.67 | ₹6.95 |
PAT Margin (%) | 21.73 | 16.36 | 17.66 |
ROE(%) | 34.22 | 27.55 | 18.43 |
ROCE(%) | 37.81 | 34.79 | 25.66 |
Total Debt/Equity(x) | 0.30 | 0.11 | 0.02 |
Key Financials |
||
Market Cap | : | ₹ 908.7 Cr |
Revenue (TTM) | : | ₹ 121.5 Cr |
Net Profit(TTM) | : | ₹ 29.1 Cr |
EPS (TTM) | : | ₹ 22.7 |
P/E (TTM) | : | 31.3 |
Industry Peers & Returns | 1W | 1M | 1Y |
SHREE GANESH REMEDIES | -0.2% | 6.8% | 9.6% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
CIPLA | -1.8% | 1% | 0.5% |
TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
LUPIN | -2.7% | 1% | 30.1% |
SHREE GANESH REMEDIES Revenues
[BOM: 540737]
Y-o-Y | 96.65 % |
5 Yr CAGR | 88.81 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹126 Cr | 96.65 | |
Mar2020 | ₹64 Cr | 81.29 | |
Mar2019 | ₹35 Cr | - |
SHREE GANESH REMEDIES Operating Profit
[BOM: 540737]
Y-o-Y | 233.99 % |
5 Yr CAGR | 118.67 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹42 Cr | 233.99 | |
Mar2020 | ₹13 Cr | 43.17 | |
Mar2019 | ₹8.74 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 69.87 % |
5 Yr CAGR | 15.81 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 33.21% | 69.87 | |
Mar2020 | 19.55% | -21.04 | |
Mar2019 | 24.76% | - |
SHREE GANESH REMEDIES Profit After Tax
[BOM: 540737]
Y-o-Y | 168.44 % |
5 Yr CAGR | 112.32 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹28 Cr | 168.44 | |
Mar2020 | ₹10 Cr | 67.94 | |
Mar2019 | ₹6.24 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 32.82 % |
5 Yr CAGR | 10.93 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 21.73 % | 32.82 | |
Mar2020 | 16.36 % | -7.36 | |
Mar2019 | 17.66 % | - |
SHREE GANESH REMEDIES Earnings Per Share (EPS)
[BOM: 540737]
Y-o-Y | 87.57 % |
5 Yr CAGR | 77.47 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹22 | 87.57 | |
Mar2020 | ₹12 | 67.91 | |
Mar2019 | ₹6.95 | - |
SHREE GANESH REMEDIES Return on Capital Employed (ROCE)
[BOM: 540737]
Y-o-Y | 8.68 % |
5 Yr CAGR | 21.39 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 37.81% | 8.68 | |
Mar2020 | 34.79% | 35.58 | |
Mar2019 | 25.66% | - |
SHREE GANESH REMEDIES Share Price vs Sensex
Current Share Price | : | ₹709.9 |
Current MarketCap | : | ₹ 908.7 Cr |
Updated EOD on | : | Apr 04,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | -0.2% |
6.8% |
9.6% |
SENSEX | -2.9% |
3.1% |
1.8% |
SHREE GANESH REMEDIES related INDICES
You may also like the below Video Courses
FAQ about SHREE GANESH REMEDIES Financials
How the annual revenues of SHREE GANESH REMEDIES have changed ?
The Revenues of SHREE GANESH REMEDIES have increased by 96.65% YoY .
How the Earnings per Share (EPS) of SHREE GANESH REMEDIES have changed?
The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has increased by 87.57 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs